The medical community is buzzing about ZPHC Retatrutide 120 , a dual-action medication showing impressive outcomes in clinical trials . This new compound, a GLP-1 activator alongside a similar agent , appears to notably decrease body weight and improve metabolic health . Clinicians are suggesting